Semen A Leyn

Oct 22, 2024 | nature.com | Darryl A Wesener |Megan Hill |Nicolas Terrapon |Bernard Henrissat |Dmitry A. Rodionov |Semen A Leyn | +1 more

AbstractSynthetic glycans (SGs) containing glycosidic linkages and structures not identified in nature offer a means for deliberately altering microbial community properties. Here pools of SG oligosaccharides were generated via polymerization of monosaccharides and screened for their ability to increase saccharolytic Bacteroides in ex vivo cultures of human fecal samples.

Jul 11, 2024 | nature.com | Claudia Zampaloni |Patrizio Mattei |Christian H. Bucher |Alexander Alanine |Vadim Baidin |Franziska Boess | +14 more

Correction to: Nature https://doi.org/10.1038/s41586-023-06873-0 Published online 3 January 2024In the version of the article initially published, three references were missing and have now been added as refs. 20–22: Schuster, M. et al. Peptidomimetic antibiotics disrupt the lipopolysaccharide transport bridge of drug-resistant Enterobacteriaceae. Sci. Adv. 9, eadg3683 (2023); Martin-Loeches, I., Dale, G. E. & Torres, A. Murepavadin: a new antibiotic class in the pipeline. Expert Rev. Anti-infect. Ther.